The U.S. Court of Appeals for the Federal Circuit has reversed two PTAB decisions invalidating Google's voice-activation patents, ruling that the prior art failed to disclose exchanging messages while remaining in a low-power mode.
As the Chinese judiciary solidifies its role in global SEP litigation, the jurisdictional battle between ZTE and Samsung in the Chongqing Intermediate People's Court underscores a critical shift. This article analyzes the strategic implications of China's growing authority in determining global FRAND licensing rates and how multinational tech companies must adapt.
With UK and Chinese courts delivering drastically different royalty determinations for Samsung and ZTE, the era of global FRAND consistency is facing its most significant challenge yet.
Moderna settles its long-standing LNP patent dispute with Arbutus and Genevant for a record-breaking $2.25 billion, setting a new benchmark for mRNA platform technology licensing.
The U.S. International Trade Commission (ITC) has officially commenced an investigation into Samsung Electronics following a complaint by Netlist, potentially threatening an import ban on key memory products including HBM and DDR5.
With an estimated $600 billion annual loss due to IP theft, the US Senate Judiciary Committee is pivoting its focus toward AI. This analysis explores the implications for global IP strategy and legal operations.
The CRISPR-Cas9 legal battle enters a critical phase as ToolGen secures key positions at the EPO, while the European Unified Patent Court (UPC) introduces the threat of multi-national injunctions.
The Federal Circuit's recent invalidation of Q Tech's patents against Walmart underscores the ongoing volatility of 35 U.S.C. § 101. We analyze why functional claims are failing and how practitioners must adapt to ensure software patent eligibility.
Moderna and Arbutus Biopharma have reached a historic $2.25 billion settlement over Lipid Nanoparticle (LNP) technology. This analysis explores the legal precedents, the valuation of platform IP, and what it means for the future of mRNA therapeutics.
As ToolGen secures key CRISPR-Cas9 RNP patents in the US and Europe, the decade-long battle over gene editing supremacy enters a high-stakes phase involving the Unified Patent Court (UPC) and billion-dollar royalties.
The landmark settlement between Moderna and Arbutus Biopharma over LNP delivery technology marks a historic turning point for the biotech industry, establishing the highest valuation yet for mRNA platform IP.
The PTAB has ruled that foreign sovereign entities do not qualify as 'persons' under the AIA, effectively barring state-owned enterprises from filing IPR petitions against US patents. This decision creates a significant procedural barrier for state-linked competitors and shifts the primary battlefield for patent invalidity to federal courts.
The entry of ToolGen into the high-stakes CRISPR patent battle against Vertex and CRISPR Therapeutics signals a new era of multi-jurisdictional litigation in gene editing.
As ToolGen secures key CRISPR-Cas9 RNP patents in the US and Europe, the landscape for gene-editing licensing shifts, signaling a high-stakes showdown at the Unified Patent Court.
In H2 2025, South Korea advanced to 18th in the Global AI Diffusion Index. For patent attorneys, this shift, combined with record KIPO application volumes, mandates a transition from manual drafting to AI-assisted workflow optimization.
The U.S. International Trade Commission (ITC) has officially launched a Section 337 investigation into Samsung Electronics' memory products. This high-stakes move by Netlist could disrupt the global AI and server supply chains, forcing a major settlement.
Recent data indicates a 41% burnout rate among legal professionals, posing a systemic risk to work product quality. This analysis explores the viability of Large Language Models (LLMs) not as creative tools, but as mechanisms to reduce low-value cognitive load in IP workflows.
The US ITC has officially launched an investigation into Samsung Electronics following Netlist's complaint. We analyze why this shift from district court to the ITC represents a critical turning point for the global semiconductor supply chain.
Tradespace’s financing and acquisition of Paragon signal a pivot from attorney productivity tools to autonomous IP monetization platforms. This analysis examines the economic implications of 'agentic' patent drafting and the potential unblocking of the innovation long tail.
Ivo's recent financing at a $355 million valuation validates the market demand for specialized contract AI over generalist copilots. This capital event signals a transition in legal operations from manual document review to continuous, AI-driven business intelligence.
The U.S. International Trade Commission (ITC) has officially launched an investigation into Samsung Electronics' memory modules following a complaint by Netlist. This move signals a shift from monetary damages to the 'nuclear option' of import bans, threatening the global AI and data center supply chains.
An eight-year, $535 million licence ends multi-jurisdictional FRAND litigation and resets the 5G IP value baseline.
